[Effect of myelopeptides on the cytolytic activity of T-lymphocytes]. 1986

I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza

To estimate myelopeptide effect on T-cell immunity a model system-mixed lymphocyte culture (MLC) with routine (1:1) and insufficient (20:1) ratio of reacting and stimulating cells was used. The latter culture was termed weakly immunogenic MLC. Myelopeptides administered into the weakly immunogenic MLC at the beginning of incubation ("0" period) at a concentration of 30 to 90 mkg/ml were shown to increase T-lymphocyte cytolytic activity by 35-50% without affecting cell proliferation. The preparation inserted into the culture on day 3 of incubation activated cytolysis by 20-35%. There was no myelopeptide effect on T-lymphocyte proliferation and cytolytic activity in normal MLC. The preparation is supposed to affect differentiation of T-killer precursors without activating DNA synthesis.

UI MeSH Term Description Entries
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
January 1986, Methods in enzymology,
I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
June 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
January 1983, Annual review of immunology,
I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
August 1976, Journal of immunology (Baltimore, Md. : 1950),
I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
February 1981, Journal of immunology (Baltimore, Md. : 1950),
I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
June 1984, Biulleten' eksperimental'noi biologii i meditsiny,
I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
September 2010, Molecular immunology,
I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
October 1986, Cellular immunology,
I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
January 1990, The Journal of biological chemistry,
I G Derevianchenko, and S N Bykovskaia, and L A Zakharova, and S V Kibza
January 1983, Immunology,
Copied contents to your clipboard!